Hypertension Diagnostics Stock Analysis
| HDII Stock | USD 0.0001 0.00 0.00% |
Hypertension Diagnostics' financial leverage is the degree to which the firm utilizes its fixed-income securities and uses equity to finance projects. Companies with high leverage are usually considered to be at financial risk. Hypertension Diagnostics' financial risk is the risk to Hypertension Diagnostics stockholders that is caused by an increase in debt. In other words, with a high degree of financial leverage come high-interest payments, which usually reduce Earnings Per Share (EPS).
Given that Hypertension Diagnostics' debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Hypertension Diagnostics is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Hypertension Diagnostics to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Hypertension Diagnostics is said to be less leveraged. If creditors hold a majority of Hypertension Diagnostics' assets, the Company is said to be highly leveraged.
Hypertension Diagnostics is overvalued with Real Value of 8.4E-5 and Hype Value of 1.0E-4. The main objective of Hypertension Diagnostics pink sheet analysis is to determine its intrinsic value, which is an estimate of what Hypertension Diagnostics is worth, separate from its market price. There are two main types of Hypertension Diagnostics' stock analysis: fundamental analysis and technical analysis.
The Hypertension Diagnostics pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Hypertension Diagnostics' ongoing operational relationships across important fundamental and technical indicators.
Hypertension |
Hypertension Pink Sheet Analysis Notes
The company recorded a loss per share of 0.0. Hypertension Diagnostics had not issued any dividends in recent years. Hypertension Diagnostics, Inc. designs, develops, manufactures, and markets proprietary noninvasive medical devices that detect subtle changes in the elasticity of arteries in the United States and internationally. Hypertension Diagnostics, Inc. was founded in 1988 and is based in Richmond Hill, Canada. Hypertension Diag operates under Shell Companies classification in the United States and is traded on OTC Exchange.The quote for Hypertension Diagnostics is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To learn more about Hypertension Diagnostics call the company at 404-449-6151 or check out https://www.hypertensiondiagnostics.com.Hypertension Diagnostics Investment Alerts
| Hypertension Diagnostics generated a negative expected return over the last 90 days | |
| Hypertension Diagnostics has some characteristics of a very speculative penny stock | |
| Hypertension Diagnostics has a very high chance of going through financial distress in the upcoming years | |
| Hypertension Diagnostics currently holds 4.69 M in liabilities. Hypertension Diagnostics has a current ratio of 0.51, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Hypertension Diagnostics until it has trouble settling it off, either with new capital or with free cash flow. So, Hypertension Diagnostics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Hypertension Diagnostics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Hypertension to invest in growth at high rates of return. When we think about Hypertension Diagnostics' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 3.79 M. Net Loss for the year was (125.39 K) with profit before overhead, payroll, taxes, and interest of 954.47 K. | |
| Hypertension Diagnostics currently holds about 5.66 K in cash with (389.28 K) of positive cash flow from operations. |
Hypertension Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 730.42 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Hypertension Diagnostics's market, we take the total number of its shares issued and multiply it by Hypertension Diagnostics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Hypertension Profitablity
The company has Profit Margin (PM) of (0.03) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average.Technical Drivers
Hypertension Diagnostics technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.Hypertension Diagnostics Price Movement Analysis
Illegal number of arguments. The output start index for this execution was zero with a total number of output elements of zero. The Weighted Moving Average calculates a weight for each value in Hypertension Diagnostics price series with the more recent values given greater weights.
Hypertension Diagnostics Outstanding Bonds
Hypertension Diagnostics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Hypertension Diagnostics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Hypertension bonds can be classified according to their maturity, which is the date when Hypertension Diagnostics has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Hypertension Diagnostics Debt to Cash Allocation
Hypertension Diagnostics currently holds 4.69 M in liabilities. Hypertension Diagnostics has a current ratio of 0.51, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Hypertension Diagnostics until it has trouble settling it off, either with new capital or with free cash flow. So, Hypertension Diagnostics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Hypertension Diagnostics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Hypertension to invest in growth at high rates of return. When we think about Hypertension Diagnostics' use of debt, we should always consider it together with cash and equity.Hypertension Diagnostics Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Hypertension Diagnostics' operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Hypertension Diagnostics, which in turn will lower the firm's financial flexibility.Hypertension Diagnostics Corporate Bonds Issued
Most Hypertension bonds can be classified according to their maturity, which is the date when Hypertension Diagnostics has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
About Hypertension Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Hypertension Diagnostics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Hypertension shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Hypertension Diagnostics. By using and applying Hypertension Pink Sheet analysis, traders can create a robust methodology for identifying Hypertension entry and exit points for their positions.
Hypertension Diagnostics, Inc. designs, develops, manufactures, and markets proprietary noninvasive medical devices that detect subtle changes in the elasticity of arteries in the United States and internationally. Hypertension Diagnostics, Inc. was founded in 1988 and is based in Richmond Hill, Canada. Hypertension Diag operates under Shell Companies classification in the United States and is traded on OTC Exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Hypertension Diagnostics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Bollinger Bands Now
Bollinger BandsUse Bollinger Bands indicator to analyze target price for a given investing horizon |
| All Next | Launch Module |
Complementary Tools for Hypertension Pink Sheet analysis
When running Hypertension Diagnostics' price analysis, check to measure Hypertension Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hypertension Diagnostics is operating at the current time. Most of Hypertension Diagnostics' value examination focuses on studying past and present price action to predict the probability of Hypertension Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hypertension Diagnostics' price. Additionally, you may evaluate how the addition of Hypertension Diagnostics to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Stocks Directory Find actively traded stocks across global markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |